Advances and innovations in living donor liver transplant techniques, matching and surgical training: Meeting report from the living donor liver transplant consensus conference

Citations Over TimeTop 10% of 2023 papers

Abstract

The practice of LDLT currently delivers limited impact in western transplant centers. The American Society of Transplantation organized a virtual consensus conference in October 2021 to identify barriers and gaps to LDLT growth, and to provide evidence-based recommendations to foster safe expansion of LDLT in the United States. This article reports the findings and recommendations regarding innovations and advances in approaches to donor-recipient matching challenges, the technical aspects of the donor and recipient operations, and surgical training. Among these themes, the barriers deemed most influential/detrimental to LDLT expansion in the United States included: (1) prohibitive issues related to donor age, graft size, insufficient donor remnant, and ABO incompatibility; (2) lack of acknowledgment and awareness of the excellent outcomes and benefits of LDLT; (3) ambiguous messaging regarding LDLT to patients and hospital leadership; and (4) a limited number of proficient LDLT surgeons across the United States. Donor-recipient mismatching may be circumvented by way of liver paired exchange. The creation of a national registry to generate granular data on donor-recipient matching will guide the practice of liver paired exchange. The surgical challenges to LDLT are addressed herein and focuses on the development of robust training pathways resulting in proficiency in donor and recipient surgery. Utilizing strong mentorship/collaboration programs with novel training practices under the auspices of established training and certification bodies will add to the breadth and depth of training.

Related Papers

• → The Consensus Development Program: Detecting Changes in Medical Practice Following A Consensus Conference on the Treatment of Prostate Cancer(1992)21 cited
• → Is Remnant Donor Volume Less Than 35 % Safe to the Donor in Living Donor Liver Transplantation(2021)1 cited
• → Is recurrence of hepatitis C worse after living donor or deceased donor liver transplantation?(2004)5 cited
• → Italian National Consensus Conference on Prostate Cancer Screening (Florence, May 17, 2003) - Final Consensus Document(2003)3 cited
• → OUTCOMES OF DONOR EVALUATIONS FOR LIVING DONOR LIVER TRANSPLANTATION (LDLT); WHO IS THE IDEAL DONOR? IS THERE ROOM FOR IMPROVEMENT?(2010)